Defense Opposition to Tolling Agreement Key Points: In summary, the defense’s opposition to the tolling agreement reflects their strategic considerations and concerns regarding potential risks and challenges in the litigation process. The court’s decision will ultimately determine the course of action moving forward.
MDL Court Updates: Tolling Agreement Standoff The MDL court has arranged a virtual interim status conference slated for May 14, 2024, followed by an in-person session on June 6, 2024. Essential documents concerning protective orders, tolling matters, and procedural motions must be submitted by May 7, 2024, as per the court’s directive. Of paramount concern…
Significant Growth in Suboxone Tooth Decay MDL In a notable development, the number of cases within the newly formed Suboxone tooth decay class action MDL has surged, more than tripling in the span of just one month. At the onset of April, the MDL commenced with a modest 44 pending cases. However, with the addition…
General vs. Specific Causation in Suboxone Tooth Decay Litigation Indivior is asserting that the current Suboxone tooth decay multidistrict litigation (MDL) necessitates a focus on general causation before delving into specific causation. In this context, general causation involves establishing that Suboxone possesses the capacity to induce dental issues, such as tooth decay, backed by scientific…
Suboxone Tooth Decay Lawsuit Filed A new lawsuit emerged that sheds light on the adverse effects of Suboxone. A resident of Prince George’s County, Maryland, prescribed the drug for opioid addiction, experienced severe tooth decay, prompting legal action to seek compensation for the resulting harm. At the heart of the lawsuit is the allegation against…
Georgia Woman Files Suboxone Lawsuit Over Dental Damage In a recent development, a Georgia woman initiated a lawsuit against Suboxone after experiencing extensive dental issues, such as tooth decay and the need for multiple extractions, due to using prescription Suboxone film. The medication was prescribed in 2016 to manage opioid use disorder resulting from an…
MDL Receives 86 Suboxone Lawsuits On April 5, 2024, it was reported that 86 lawsuits related to Suboxone have been filed into multidistrict litigation (MDL). These lawsuits are part of a trend where plaintiff law firms are rushing to file claims before the statute of limitations expires in states with a two-year limit. This surge…
Dismissal of MonoSol from Suboxone Litigation In a development in the Suboxone litigation on April 4, 2024, MonoSol, a defendant named in some Suboxone claims, was dismissed from the litigation. MonoSol, previously dismissed from antitrust claims involving Suboxone and product hopping, is no longer part of this litigation. This dismissal marks progress in the litigation…
Suboxone Dental Problems MDL: 44 Lawsuits Filed in First Six Weeks As of April 1, 2024, the Multidistrict Litigation (MDL) for cases alleging Suboxone caused severe dental problems has seen 44 lawsuits filed in just six weeks since its creation in February. These cases are being filed directly into the MDL in the Northern District…
MDL Judge Issues Order Streamlining Filing Process for Suboxone Film Lawsuits The MDL judge issued Case Management Order (CMO No. 3) for the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation MDL. This order, agreed upon by all parties involved, outlines the process for directly filing and serving lawsuits related to Suboxone film within this multidistrict litigation…